Señales en vivo de BIOG-B.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:29):

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other...

Stats
Volumen de hoy	73 345.00
Volumen promedio	118 919
Capitalización de mercado	11.10B
EPS	SEK0 ( 2024-02-06 )
Próxima fecha de ganancias	( SEK0.960 ) 2024-05-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	31.52
ATR14	SEK0.132 (0.12%)

Volumen Correlación

Largo: -0.06 (neutral)

Corto: 0.98 (very strong)

Signal:(57.294) Expect same movement, but be aware

BioGaia AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioGaia AB (publ) Correlación - Moneda/Commodity

-0.61
( weak negative )

-0.59
( weak negative )

0.00
( neutral )

-0.59
( weak negative )

-0.10
( neutral )

0.68
( moderate )

BioGaia AB (publ) Finanzas

Annual	2023
Ingresos:	SEK1.30B
Beneficio Bruto:	SEK950.19M (73.29 %)
EPS:	SEK3.62

FY	2023
Ingresos:	SEK1.30B
Beneficio Bruto:	SEK950.19M (73.29 %)
EPS:	SEK3.62

FY	2022
Ingresos:	SEK1.10B
Beneficio Bruto:	SEK801.93M (72.64 %)
EPS:	SEK3.70

FY	2021
Ingresos:	SEK785.11M
Beneficio Bruto:	SEK582.95M (74.25 %)
EPS:	SEK9.72

Financial Reports:

No articles found.

BioGaia AB (publ)

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Actualizaciones en tiempo real para BioGaia AB (publ) [BIOG-B.ST]

Upcoming Earnings Alert